Track Kymera Therapeutics's inventory ($-5.8M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Kymera Therapeutics (KYMR) currently reports a inventory of $-5.8M as of June 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore Kymera Therapeutics's inventory history and peer comparisons.
Kymera Therapeutics's inventory changed from $0 to $-5.8M (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Kymera Therapeutics reported $-5.8M in inventory as of June 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current inventory of $-5.8M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Kymera Therapeutics, and consider following KYMR for alerts when major investors trade the stock.
Kymera Therapeutics is classified in the Healthcare sector. On inventory, it currently shows $-5.8M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing KYMR with unrelated industries.